Company: Johnson & Johnson
Ticker: JNJ
Form: 10-K
Filed: 2026-02-11
Fiscal Period: {"fp": "FY", "fy": 2025}

Question: What was Johnson & Johnson's total assets in fiscal year 2025?
Question Type: value_lookup

Concept: Assets
Answer (Numeric): 199210.0
Answer (Display): $199,210 million
Unit: USD millions

Evidence:
[{"chunk_id": "101", "equivalent_chunk_ids": ["101"], "section": "Johnson & Johnson and subsidiaries consolidated balance sheets", "supports": ["main"], "text": "At December 28, 2025 and December 29, 2024\n(Dollars in Millions Except Share and Per Share Amounts) (Note 1)\nAssets\nCurrent assets\nCash and cash equivalents (Notes 1 and 2)\n19,709\n24,105\nMarketable securities (Notes 1 and 2)\nAccounts receivable trade, less allowances $\n(2024, $\n17,178\n14,842\nInventories (Notes 1 and 3)\n14,191\n12,444\nPrepaid expenses and other receivables\n4,153\n4,085\nTotal current assets\n55,624\n55,893\nProperty, plant and equipment, net (Notes 1 and 4)\n23,169\n20,518\nIntangible assets, net (Notes 1 and 5)\n50,403\n37,618\nGoodwill (Notes 1 and 5)\n48,772\n44,200\nDeferred taxes on income (Note 8)\n6,874\n10,461\nOther assets\n14,368\n11,414\nTotal assets\n199,210\n180,104\nLiabilities and Shareholders’ Equity\nCurrent liabilities\nLoans and notes payable (Note 7)\n8,495\n5,983\nAccounts payable\n11,991\n10,311\nAccrued liabilities\n8,594\n8,549\nAccrued rebates, returns and promotions\n19,124\n17,580\nAccrued compensation and employee related obligations\n4,534\n4,126\nAccrued taxes on income (Note 8)\n1,388\n3,772\nTotal current liabilities\n54,126\n50,321\nLong-term debt (Note 7)\n39,438\n30,651\nDeferred taxes on income (Note 8)\n6,791\n2,448\nEmployee related obligations (Notes 9 and 10)\n6,957\n7,255\nLong-term taxes payable (Note 1)\nOther liabilities\n9,868\n17,549\nTotal liabilities\n117,666\n108,614\nCommitments and Contingencies (Note 19)\nShareholders’ equity\nPreferred stock — without par value (authorized and unissued\n2,000,000\nshares)\nCommon stock — par value $\n1.00\nper share (Note 12) (authorized\n4,320,000,000\nshares; issued\n3,119,843,000\nshares)\n3,120\nAccumulated other comprehensive income (loss) (Note 13)\n14,930\n11,741\nRetained earnings and Additional-paid-in-capital\n168,978\n155,791\nLess: common stock held in treasury, at cost (Note 12) (\n711,904,000\nshares and\n712,921,000\nshares)\n75,624\n75,680\nTotal shareholders’ equity\n81,544\n71,490\nTotal liabilities and shareholders’ equity\n199,210\n180,104\nSee Notes to Consolidated Financial Statements\n2025 Annual Report"}]

Derivation: